Sanofi-aventis is one of the world's leading pharmaceutical companies and number 1 in Europe.

Present in more than 100 countries, with around 11,000 scientists, we have around 100,000 employees working to improve health and wellbeing. Our Global headquarters are in Paris, France.

Sanofi-aventis focuses its activities on 7 major therapeutic areas: 

• Cardiovascular diseases
• Thrombosis
• Oncology
• Central Nervous System
• Metabolic Disorders
• Internal Medicine
• Vaccines  

The sanofi-aventis portfolio of marketed products includes several medicines that are world leaders in their respective classes, in the areas of thrombosis, cardiovascular disease, sleep disorders, epilepsy, diabetes and cancer.

The mission that sanofi-aventis holds towards research:

To truly find revolutionary drugs that
provides us with effective therapeutic solutions
to patients around the world.

Sanofi-aventis is one of the leading R&D organizations in the world. The foundation to its worldwide growth is a highly productive and innovative R&D group, which contains about 11,000 scientists working in more than 20 research centres, in three continents to create innovative therapeutic treatments. The scientific personnel are keeping in touch with the patients’ needs in order to reassure the importance of health. There are around thirty R&D projects which are currently in advanced stages of development. 


For more information about sanofi-aventis worldwide, visit www.sanofi-aventis.com.